A patient with permanent atrial fibrillation and very high bleeding risk – when is the optimal time to refer for left atrial appendage occluder device implantation?

Autor:	Vlasta Soukup Podravec, Iva Ladić, Kristina Milevoj Križić, Darija Baković Kramarić, Ante Anic, Ivana Smoljan, Gabriela Bašković, Sandra Prša, Andreja Čleković Kovačić, Ivana Petrović Juren
Jazyk:	angličtina
Rok vydání:	2019
Předmět:	left atrial appendage thrombus bleeding risk Amplatzer Amulet occluder device medicine.medical_specialty Left atrial business.industry Internal medicine medicine Cardiology Atrial fibrillation Thrombus Cardiology and Cardiovascular Medicine Time optimal medicine.disease business
Zdroj:	Cardiologia Croatica Volume 14 Issue 9-10
ISSN:	1848-5448 1848-543X
Popis:	Introduction: Most patients with atrial fibrillation (AF) should receive anticoagulant therapy to reduce the risk of systemic embolization. However, there are varying degrees of bleeding risk associated with anticoagulation thus reducing the number of candidates for this therapy. The left atrial appendage (LAA) is the usual source of clot embolisms. Percutaneous approaches, often referred to as LAA exclusion procedures, mechanically prevent embolization of LAA thrombi.1,2 We consider the placement of percutaneous LAA Occlusion Device (Amplatzer Amulet device) a good choice for patients with high bleeding risk.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35387466a42fea2a91d276b62d158e2f https://hrcak.srce.hr/file/330227 Zobrazit plný text záznamu